Drugs that contain Dextromethorphan Hydrobromide; Quinidine Sulfate

1. List of Nuedexta drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8227484 AVANIR PHARMS Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Jul, 2023

(5 months from now)

US7659282 AVANIR PHARMS Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Aug, 2026

(3 years from now)

Market Authorisation Date: 29 October, 2010

Treatment: Treatment of pseudobulbar affect

Dosage: CAPSULE;ORAL

How can I launch a generic of NUEDEXTA before it's patent expiration?
More Information on Dosage

NUEDEXTA family patents

16

United States

12

Japan

9

Australia

7

Korea, Republic of

6

European Union

5

Israel

2

Hong Kong

2

Poland

2

Spain

2

Slovenia

2

Hungary

2

Portugal

2

Norway

2

Denmark

1

Austria

1

Luxembourg

1

Germany

1

Cyprus

1

Belgium

1

Russia

1

Canada

1

Taiwan, Province of China

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in